Robert F. Williamson III - 25 Nov 2024 Form 4/A - Amendment Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: Director
Signature: /s/ Robert Williamson by Chris Nenno, as Attorney-in-Fact
Issuer symbol: CATX
Transactions as of: 25 Nov 2024
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 04 Dec 2024, 17:17:04 UTC
Date Of Original Report: 27 Nov 2024
Previous filing: 24 Jun 2024
Next filing: 05 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CATX	Common Stock						48,645	25 Nov 2024	Direct	F1
holding	CATX	Common Stock						366	25 Nov 2024	By RFW3 Revocable Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Beneficial ownership was reported to be 430,058 and should have been reported as 48,645.
F2	Beneficial ownership was reported to be 3,663 and should have been reported as 366.

Remarks:

This Form 4/A is being filed to correct certain previously reported information regarding the beneficial ownership of the Reporting Person as reflected in the original Form 4 filed on November 27, 2024 (the "Original Form 4"). Certain amounts reported in the Original Form 4 did not reflect the 1-for-10 reverse stock split effected by the Issuer in June 2024; such amounts have been updated accordingly herein.